<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03044834</url>
  </required_header>
  <id_info>
    <org_study_id>35RC15_3009_PPB</org_study_id>
    <secondary_id>15.18</secondary_id>
    <secondary_id>15.468</secondary_id>
    <secondary_id>915465</secondary_id>
    <nct_id>NCT03044834</nct_id>
  </id_info>
  <brief_title>Review of the Paediatric Pleuropulmonary Blastoma French Series</brief_title>
  <acronym>PPB</acronym>
  <official_title>Review of the Paediatric Pleuropulmonary Blastoma French Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pleuropulmonary blastoma is a rare embryonic malignant tumour that remains the most frequent
      malignant tumour of the lung in childhood. The International Pleuro pulmonary Blastoma
      Registry (IPPB) found only 220 cases in 2009 and 350 in 2015. In France, 20 cases were
      identified in 2009.

      Three histologies are described: type 1 purely cystic, type 2 combined and type 3 solid.
      Median age at diagnostic is 12 months, 35 months and 41 months respectively. Evolution is
      possible from type 1 to type 2 or 3 in 10% of the cases.

      Since 2009, DICER 1 mutations research is proposed systematically to all families.

      PPB symptoms are usually non-specific. Diagnostic is evoked when imaging work up shows
      bubbles or solid lesions, and confirmed by pathological analysis. However the diagnosis can
      be difficult because of the proximity with congenital cystic adenomatoid malformation.

      The French society of paediatric oncology recommends surgery at first instance. PPB type 1
      remains a problem because some are still misdiagnosed as CCAM, a benign lesion. Chemotherapy
      depends on the PPB type and the quality of the resection. There is a real interest to analyse
      the French series.

      The prognosis of type 2 and 3 is low with a 5 years survival rate of 45-60%, whereas type 1
      survival rate is 91%. The French experience reports a 100% survival rate in type 1 and 48% in
      type 2 and 3. Other prognostic factors are initial size of the tumour, extra pulmonary
      invasion and quality of surgery.

      Early local relapses are possible and late ones concern more often type 2 and 3 with more
      cerebral metastasis.

      In 2009, the french cases were collected, but no update has been performed since. The aim of
      this retrospective review of the cases since 2000, is to audit the care of PPB patients in
      France and update the French rare tumour database.

      Evoking PPB diagnosis is difficult when imaging shows a neonatal cystic lesion. There are no
      radiologic criteria in the literature that differentiate congenital pulmonary cystic lesion
      and PPB type 1. Radiological presentation is however overlapping. Another aim of this study
      will be to look for a predictive sign of type 1 PPB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicentre retrospective study
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Anticipated">July 9, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 9, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Within 5 years from the diagnosis</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression free survival</measure>
    <time_frame>Within 5 years from the diagnosis</time_frame>
    <description>Characterize the evolution and the global care of PPB in the French series</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>State of PPB surgical care</measure>
    <time_frame>Within 5 years from the diagnosis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiology sign</measure>
    <time_frame>Within 5 years from the diagnosis</time_frame>
    <description>Identification of a type 1 PPB predictive radiological sign</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pleuropulmonary Blastoma</condition>
  <arm_group>
    <arm_group_label>Pleuropulmonary Blastoma</arm_group_label>
    <description>Patients born between 01/01/2000 and 01/01/2016 ;
Followed up for PPB
Treated in a French department of paediatric oncology or paediatric surgery
Study agreement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PPB</intervention_name>
    <description>Global current care</description>
    <arm_group_label>Pleuropulmonary Blastoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients born between 01/01/2000 and 01/01/2016, followed up for PPB, treated in a French
        department of paediatric oncology or paediatric surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients born between 01/01/2000 and 01/01/2016 ;

          -  Followed up for PPB

          -  Treated in a French department of paediatric oncology or paediatric surgery

          -  Study agreement

        Exclusion Criteria:

          -  Part of the care out of France

          -  Study disagreement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis ARNAUD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexis ARNAUD, MD</last_name>
    <email>alexis.arnaud@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume PODEVIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume PODEVIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile VERITE-GOULARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cécile VERITE-GOULARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odile MINCKES, MD</last_name>
    </contact>
    <investigator>
      <last_name>Odile MINCKES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique PLANTAZ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dominique PLANTAZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kremlin-Bicêtre Hospital</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent GUERIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Florent GUERIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lille University Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hélène SUDOUR-BONNANGE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hélène SUDOUR-BONNANGE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyon Universty Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric HAMEURY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric HAMEURY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas ANDRE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nicolas ANDRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas KALFA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nicolas KALFA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula BORREGO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caroline THOMAS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Caroline THOMAS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne DEVILLE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne DEVILLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Necher Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naziha KHEN-DUNLOP, MD</last_name>
    </contact>
    <investigator>
      <last_name>Naziha KHEN-DUNLOP, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Poitiers University Hospital</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guillaume LEVARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume LEVARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric MILLOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Curie Institute</name>
      <address>
        <city>Saint-Cloud</city>
        <zip>92000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel ORBACH, MD</last_name>
    </contact>
    <investigator>
      <last_name>Daniel ORBACH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Réunion University Hospital</name>
      <address>
        <city>Saint-Paul</city>
        <zip>97000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves REGUERRE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yves REGUERRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ollivier ABBO, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ollivier ABBO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tours University Hospital</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne JOURDAIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne JOURDAIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gustave Roussy Institute</name>
      <address>
        <city>Villejuif</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Véronique MINARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Véronique MINARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2017</study_first_submitted>
  <study_first_submitted_qc>February 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Blastoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

